Blachère NE - Search Results

1

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

Maki RG, D'Adamo DR, Keohan ML, Saulle M, Schuetze SM, Undevia SD, Livingston MB, Cooney MM, Hensley ML, Mita MM, Takimoto CH, Kraft AS, Elias AD, Brockstein B, Blachère NE, Edgar MA, Schwartz LH, Qin LX, Antonescu CR, Schwartz GK. Maki RG, et al. Among authors: blachere ne. J Clin Oncol. 2009 Jul 1;27(19):3133-40. doi: 10.1200/JCO.2008.20.4495. Epub 2009 May 18. J Clin Oncol. 2009. PMID: 19451436 Free PMC article. Clinical Trial.

2

Antigens recognized by autologous antibodies of patients with soft tissue sarcoma.

Segal NH, Blachere NE, Shiu HY, Leejee S, Antonescu CR, Lewis JJ, Wolchok JD, Houghton AN. Segal NH, et al. Among authors: blachere ne. Cancer Immun. 2005 Mar 4;5:4. Cancer Immun. 2005. PMID: 15745419

3

Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics.

Segal NH, Blachere NE, Guevara-Patiño JA, Gallardo HF, Shiu HY, Viale A, Antonescu CR, Wolchok JD, Houghton AN. Segal NH, et al. Among authors: blachere ne. Cancer Immun. 2005 Feb 1;5:2. Cancer Immun. 2005. PMID: 15683221

4

Cellular immune suppression in paraneoplastic neurologic syndromes targeting intracellular antigens.

Orange D, Frank M, Tian S, Dousmanis A, Marmur R, Buckley N, Parveen S, Graber JJ, Blachère N, Darnell RB. Orange D, et al. Arch Neurol. 2012 Sep;69(9):1132-40. doi: 10.1001/archneurol.2012.595. Arch Neurol. 2012. PMID: 22566506 Free PMC article. Clinical Trial.

5

Strategies to overcome immune ignorance and tolerance.

Perales MA, Blachere NE, Engelhorn ME, Ferrone CR, Gold JS, Gregor PD, Noffz G, Wolchok JD, Houghton AN. Perales MA, et al. Among authors: blachere ne. Semin Cancer Biol. 2002 Feb;12(1):63-71. doi: 10.1006/scbi.2001.0397. Semin Cancer Biol. 2002. PMID: 11926414 Review.

6

Immunity against cancer: lessons learned from melanoma.

Houghton AN, Gold JS, Blachere NE. Houghton AN, et al. Among authors: blachere ne. Curr Opin Immunol. 2001 Apr;13(2):134-40. doi: 10.1016/s0952-7915(00)00195-3. Curr Opin Immunol. 2001. PMID: 11228404 Review.

7

Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens.

Wolchok JD, Srinivasan R, Perales MA, Houghton AN, Bowne WB, Blachere NE. Wolchok JD, et al. Among authors: blachere ne. Cancer Immun. 2001 Aug 16;1:9. Cancer Immun. 2001. PMID: 12747770

8

Xenogeneic DNA immunization in melanoma models for minimal residual disease.

Hawkins WG, Gold JS, Blachere NE, Bowne WB, Hoos A, Lewis JJ, Houghton AN. Hawkins WG, et al. Among authors: blachere ne. J Surg Res. 2002 Feb;102(2):137-43. doi: 10.1006/jsre.2001.6302. J Surg Res. 2002. PMID: 11796010

9

The role of lipopolysaccharide in T-cell responses following DNA vaccination.

Hawkins WG, Trcka J, Segal N, Blachere NE, Gold JS, Moroi Y, Bowne WB, Lewis JJ, Wolchok JD, Houghton AN. Hawkins WG, et al. Among authors: blachere ne. Vaccine. 2003 Mar 28;21(13-14):1548-53. doi: 10.1016/s0264-410x(02)00676-x. Vaccine. 2003. PMID: 12615452

10

FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor.

Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P, Houghton AN. Ramirez-Montagut T, et al. Among authors: blachere ne. Oncogene. 2004 Jul 15;23(32):5435-46. doi: 10.1038/sj.onc.1207730. Oncogene. 2004. PMID: 15133496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters